Stifel Nicolaus Reiterates “Hold” Rating for Abcam Plc (ABC)
Abcam Plc (LON:ABC)‘s stock had its “hold” rating restated by stock analysts at Stifel Nicolaus in a report released on Tuesday, May 2nd. They currently have a GBX 890 ($11.58) price objective on the stock. Stifel Nicolaus’ target price would indicate a potential downside of 8.06% from the company’s current price.
Several other equities analysts have also issued reports on the stock. Numis Securities Ltd lowered shares of Abcam Plc to a “hold” rating and set a GBX 912 ($11.86) price objective on the stock. in a report on Tuesday, March 7th. JPMorgan Chase & Co. restated a “neutral” rating and issued a GBX 678 ($8.82) target price on shares of Abcam Plc in a research note on Tuesday, March 7th. Peel Hunt restated a “hold” rating and issued a GBX 750 ($9.76) target price on shares of Abcam Plc in a research note on Monday, March 6th. Finally, Panmure Gordon reiterated a “sell” rating and set a GBX 680 ($8.85) price objective on shares of Abcam Plc in a research note on Monday, March 20th. One analyst has rated the stock with a sell rating and four have given a hold rating to the company. Abcam Plc has an average rating of “Hold” and a consensus price target of GBX 819.20 ($10.66).
Shares of Abcam Plc (LON:ABC) traded up 0.21% during midday trading on Tuesday, hitting GBX 968.00. The company had a trading volume of 509,896 shares. The firm’s 50 day moving average is GBX 893.86 and its 200 day moving average is GBX 843.39. The company’s market capitalization is GBX 1.96 billion. Abcam Plc has a 52 week low of GBX 619.00 and a 52 week high of GBX 987.00.
WARNING: “Stifel Nicolaus Reiterates “Hold” Rating for Abcam Plc (ABC)” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/05/24/abcam-plcs-abc-hold-rating-reiterated-at-stifel-nicolaus-updated-updated.html.
In other news, insider Alan Thomas Hirzel acquired 6,000 shares of the business’s stock in a transaction on Wednesday, March 22nd. The stock was bought at an average price of GBX 809 ($10.52) per share, with a total value of £48,540 ($63,145.57).
About Abcam Plc
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Stock Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related stocks with our FREE daily email newsletter.